Pentokey Organy

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE702E01015
  • NSEID:
  • BSEID: 524210
INR
48.30
3.36 (7.48%)
BSENSE

Dec 05

BSE+NSE Vol: 304

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Pentokey Organy (India) Ltd stock-summary
stock-summary
Pentokey Organy (India) Ltd
Micro Cap
Commodity Chemicals
Pentokey Organy (India) Ltd was incorporated on November 26, 1986. The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde. Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices.
Company Coordinates stock-summary
Company Details
509 Western Edge I Western edg, Express Highway warehouse Mumbai Maharashtra : 400066
stock-summary
Tel:
stock-summary
investors@pentokey.com
Registrar Details
Datamatics Financial Services Ltd , (Formerly Datamatics Financial Services Ltd) , Plot No A / 16 & A / 17, MIDC, Part B, Cross Lane, Marol , Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 6.27 Cr
Number of Shares
62.73 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Dec-2012
62.73
6.27
638296
10
Bonus
13-Dec-2012
62.73
6.27
638296
10
Bonus
31-Mar-2009
56.34
5.63
2800000
10
Unspecified
31-Mar-2009
56.34
5.63
2800000
10
Unspecified
31-Mar-2008
28.34
2.83
225550
10
Allotment of Equity To Others
31-Mar-2008
28.34
2.83
225550
10
Allotment of Equity To Others
17-Jan-2008
1.04
2.61
0
2.5
Capital Reduction
17-Jan-2008
26.09
2.61
-7826349
10
Consolidation of Shares
17-Jan-2008
1.04
2.61
0
2.5
Capital Reduction
17-Jan-2008
26.09
2.61
-7826349
10
Consolidation of Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.06%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Purshottam Kejriwal (35.72%)

Highest Public shareholder

Modi Jaswantlal Kantilal (7.79%)

Individual Investors Holdings

16.31%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Devendra J Shrimanker
Independent Director
0
Prajakta Shidhore
Independent Director
0
Arun Goenka
Director
0
Purusottam Kejriwal
Director
0
Divya Desai
Company Sec. & Compli. Officer
0
Kostuv Kejriwal
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase Trading Pharma Produc
1.0522
0%
 
100
Purchase Trading Pharma Produc
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Others
0.23
2.48%
 
2.48
Others
97.52
Others
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 31 Cr (Micro Cap)

stock-summary
P/E

39.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.54

stock-summary
Return on Equity

7.05%

stock-summary
Price to Book

2.76